首页> 外文期刊>Reviews in Endocrine and Metabolic Disorders >Bisphenol A: Targeting metabolic tissues
【24h】

Bisphenol A: Targeting metabolic tissues

机译:双酚A:靶向代谢组织

获取原文
获取原文并翻译 | 示例
           

摘要

The prevalence of obesity, metabolic syndrome and type 2 diabetes has dramatically increased worldwide over the last few decades. Although genetic predisposition and lifestyle factors like decreased physical activity and energy-dense diet are well-known factors in the pathophysiology of these conditions, accumulating evidence suggests that the increase in endocrine disrupting chemicals (EDCs) in the environment also explains a substantial part of the incidence of these metabolic diseases. Bisphenol A (BPA) is one of the highest-volume chemicals produced worldwide. Most people are exposed to it daily by consuming food and beverages into which BPA has leached from polycarbonate containers, including reusable bottles and baby bottles. Although initially considered to be a weak environmental estrogen, BPA may be similar in potency to 17β-estradiol in stimulating cellular responses, especially at low but environmentally relevant doses (nM), as more recent studies have demonstrated. In this review, we summarize both epidemiological evidence and in vivo experimental data that point to an association between BPA exposure and the induction of insulin resistance and/or disruption of pancreatic beta cell function and/or obesity. We then discuss the in vitro data and explain the potential mechanisms involved in the metabolic disorders observed after BPA exposure.
机译:在过去的几十年中,肥胖,代谢综合征和2型糖尿病的患病率在全世界范围内急剧增加。尽管遗传易感性和生活方式因素(例如减少的体育活动和高能量的饮食)是这些疾病的病理生理学中众所周知的因素,但越来越多的证据表明,环境中内分泌干扰物(EDCs)的增加也解释了其中的很大一部分。这些代谢性疾病的发生率。双酚A(BPA)是全球生产量最大的化学品之一。大多数人每天都通过食用BPA从聚碳酸酯容器(包括可重复使用的奶瓶和奶瓶)中浸出的食品和饮料来接触食品。尽管最初被认为是弱的环境雌激素,但是BPA在刺激细胞反应方面的功效可能与17β-雌二醇相似,尤其是在低剂量但与环境有关的剂量(nM)时,正如最近的研究表明的那样。在这篇综述中,我们总结了流行病学证据和体内实验数据,这些数据指出了BPA暴露与胰岛素抵抗的诱导和/或胰腺β细胞功能和/或肥胖的破坏之间的联系。然后,我们讨论了体外数据,并解释了BPA暴露后所观察到的代谢异常所涉及的潜在机制。

著录项

  • 来源
    《Reviews in Endocrine and Metabolic Disorders》 |2015年第4期|299-309|共11页
  • 作者单位

    Centre Hospitalier Universitaire de Nice Hôpital de l’Archet 2 Service d’Endocrinologie Diabétologie et Médecine de la Reproduction">(1);

    Université de Nice-Sophia Antipolis Faculté de Médecine Institut Signalisation et Pathologie (IFR 50)">(2);

    Institut National de la Santé et de la Recherche Médicale (INSERM) UMR U1065/UNS Centre Méditerranéen de Médecine Moléculaire (C3M) Equipe 5 “Environnement Reproduction et Cancers Hormono-Dépendants”">(3);

    Centre Hospitalier Universitaire de Nice Hôpital de l’Archet 2 Service d’Endocrinologie Diabétologie et Médecine de la Reproduction">(1);

    Université de Nice-Sophia Antipolis Faculté de Médecine Institut Signalisation et Pathologie (IFR 50)">(2);

    Institut National de la Santé et de la Recherche Médicale (INSERM) UMR U1065/UNS Centre Méditerranéen de Médecine Moléculaire (C3M) Equipe 5 “Environnement Reproduction et Cancers Hormono-Dépendants”">(3);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Bisphenol A; Diabetes; Type 2 diabetes; Obesity; Xenoestrogen; Estrogens; Fetal programming; Endocrine disruptors;

    机译:双酚A;糖尿病;2型糖尿病;肥胖;异雌激素;雌激素;胎儿编程;内分泌干​​扰物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号